Disability and handicap in dermatology

International Journal of Dermatology

Volumn 35, Issue 5, 1996, Pages 305-311

  Finlay, Andrew Y ^a   Ryan, Terence J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISABILITY; HUMAN; MEASUREMENT; QUALITY OF LIFE; REVIEW; SKIN DISEASE; SOCIAL ASPECT;

EID: 0029883015     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb03628.x     Document Type: Review

References (60)

1. Ryan TJ. Healthy skin for all. Int J Dermatol 1994; 33: 829-835.
2. International classification of impairments, disabilities and handicaps. Geneva: World Health Organization, 1980.
3. Martial (c.40-c.104 AD). Epigrammatica, Book 6, no. 70. In: Partington A, ed. The Oxford dictionary of quotations. Oxford: Oxford University Press, 1992:449.
4. Brayhoy ME. The sociological effects on an individual with Hansen's disease. The Star 1984; 43:4-14.
5. Reddy NBB, Satpathy SK, Krishnan SAR, Srinivasan T. Social aspects of leprosy: a case study in Zaria, Northern Nigeria. Lepr Rev 1985; 56:2.3-25.
6. Sulzherger MB, Zaidens SH. Psychogenic factors in dermatologic disorders. Med Clin North Am 1948; 32: 669-685.
7. Whitmore CW. Cutaneous impairment, disability and rehabilitation. Cutis 1970; 6:989-992.
8. Robinson HM. Measurement of impairment and disability in dermatology. Arch Dermatol 1973; 108:207-209.
9. Samitz MH. Assessment of cutaneous impairment and disability. In: Maibach HI, Gellin GA, eds. Occupational and industrial dermatology. Ch. 19. Chicago, IL: Yearbook Medical Publishers, 1982:165-169.
10. Committee on rating of mental and physical impairment. The skin. JAMA 1970; 21 1:106-112.
11. Molin L. Psoriasis. Acta Derm Venereol Stockh 1973; (Suppl 72):1-125.
12. Jowett S, Ryan TJ. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20:425-429.
13. Ryan TJ. Disability in dermatology. Br J Hosp Med 1991; 46:33-36.
14. Russell PS. Dermatology in the Oregon Plan with implications for health care plans in other states. Arch Dermatol 1994; 130:709-712.
15. Maynard A. Requirements for health care purchaser. In: Walker SR, Rosser RM, eds. Quality of life assessment: key issues in the 1990s. London: Kluwer Academic Publishers, 1993:413-426.
16. Shorvon SD, Hart YM, Sander JWAS, Andel F van. The management of epilepsy in developing countries: an "iceberg" manual. International congress and symposium series. Vol. 175. London: Royal Society of Medicine Services, 1991:1-66.
17. Berry JW. Cultural and ethnic factors in health. Cambridge handbook of psychology, health and medicine. Cambridge, UK: Cambridge University Press, 1995.
18. Frank AO. The family and disability - some reflections on culture: discussion paper. J R Soc Med 1989; 82: 666-668.
19. Ingram JT. The significance and management of psoriasis. BMJ 1954; 2:823-828.
20. Stankler I. The effect of psoriasis on the sufferer. Clin Exp Dermatol 1981; 6:303-306.
21. Jobling RG. Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976; 1:233-236.
22. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118:195-201.
23. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
24. Jobling R. Psoriasis and its treatment in psycho-social perspective. Rev Contemp Pharmacother 1992; 3: 339-345.
25. Logan RA. Self help groups for patients with chronic skin diseases. Br J Dermatol 1988; 118:505-508.
26. Price ML, Mottahedin I, Mayo PR. Can psychotherapy help patients with psoriasis? Clin Exp Dermatol 1991; 16:114-117.
27. Lowe JG. The stigma of acne. Br J Hosp Med 1993; 49:809-812.
28. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115:386.
29. Lawson V, Lewis-Jones MS, Reid P, et al. Family impact of childhood atopic eczema. Br J Dermatol 1995; 133 (Suppl 45):19.
30. Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want? Clin Exp Dermatol 1993; 18:516-522.
31. Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1993; 31:49-53.
32. Franks PJ, Moffatt CJ, Connolly M, et al. Community leg ulcer clinics: effects on quality of life. Phlebology 1994; 9:83-86.
33. Lanigan S. The stigma of port-wine stains. Br J Hosp Med 1991; 45: 274-276.
34. Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res 1993; 2:341-348.
35. Simpson NB. Social and economic aspects of acne and the cost-effectiveness of isotretinoin. J Dermatol Treat 1993;4(Suppl 2):S6-S9.
36. Mallon E, Newton JN, Klassen A, et al. Standard patient-assessed quality of life instruments can be used to measure the benefits of acne treatment. Br J Dermatol 1995;133(Suppl 45):35-36.
37. Shuster S. A misdiagnosed case of Cinderella syndrome. Dermatol Int 1994; 3:6.
38. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990; 123:751-756.
39. Bergner M, Bobbit RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19:787-805.
40. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. Br J Dermatol 1993; 129:422-430.
41. Blackford S, Roberts DL, Salek MS, Finlay AY. Basal cell carcinomas and their treatment cause little handicap - the reason for delayed presentation? J Dermatol Treat 1994; 5:248.
42. Ware JE. Measuring patient's views: the optimum outcome measurement. BMJ 1993; 306:1429-1430.
43. Root S, Kent G, Al-Abadie MSK. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189:234-237.
44. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9:789-793.
45. Ryan TJ. The confident nude or whither dermatology. Dermatol Practice 1987; 5:8-18.
46. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQ1): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-216.
47. Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol. (In press)
48. Blackford S, Roberts DL, Finlay AY. What is the impact on quality of life of the skin manifestations of Behçet's syndrome: Br J Dermatol 1995; 133(Suppl 45):35-36.
49. Kurwa H, Finlay AY. Dermatology inpatient admission greatly improves life quality. Br J Dermatol 1995; 133: 575-578.
50. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQL): initial validation and practical use. Br J Dermatol 1995; 132:942-949.
51. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12:8-11.
52. Kent G, Al-Abadie M. The Psoriasis Disability Index - further analyses. Clin Exp Dermatol 1993; 18:414-416.
53. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132:236-244.
54. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127:13-17.
55. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17:1-3.
56. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14:194-198.
57. Layton AM. Psychological assessment of skin disease. Interfaces Dermatol 1994; 1:9-11.
58. Eun HC, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol 1990; 2:9-12.
59. Katsambas A. Quality of life in dermatology and the FADV. J Eur Acad Dermatol Venereol 1994; 3:211-214.
60. Kaufman A, Mariam SGM, Neville J. The social dimension of leprosy. London: International Federation of Anti-Leprosy Associations, 1982:110.